Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127430-19-000119
Filing Date
2019-11-14
Accepted
2019-11-14 16:14:25
Documents
2
Period of Report
2019-11-12

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 1510
2 desjardins_poa.htm EX-24 3651
  Complete submission text file 0001127430-19-000119.txt   6554
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Issuer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 FINDERNE AVENUE BRIDGEWATER NJ 08807
Business Address
Desjardins Clarissa (Reporting) CIK: 0001793390 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-30739 | Film No.: 191220322